A 130% year-on-year spike in viewership for iQIYI International signals a shift in global streaming habits, as the platform’s dual-engine strategy—pairing premium long-form Chinese dramas with high-intensity micro dramas—successfully captures diverse markets from Southeast Asia to Latin America through aggressive localization and mobile-first content delivery.
Hackensack-based manufacturer Clip Strip Corp. is rolling out a broad strategic investment program to modernize its retail support infrastructure. The company is pivoting toward digital commerce enhancements, expanded international distribution, and new product lines including electronic shelf labels to meet shifting demands from global retail partners and consumers.
After six decades as a household staple, New Jersey-based Lola Products is shifting its focus toward a modern resurgence. The company, which spent years primarily as a private-label manufacturer, is now channeling its manufacturing expertise into a new wave of branded consumer goods, digital commerce, and international market expansion.
Patients may soon receive cancer treatment while sitting upright as TibaRay moves its Galactica technology into production. The Silicon Valley firm, born from Stanford University research, is now manufacturing its first systems, aiming to replace aging linear accelerators with more precise and compact equipment.
Ionis Pharmaceuticals shares plummeted more than 20% on July 9, 2026, after the company revealed its CARDIO-TTRansform trial missed its primary endpoint. Law firm Levi & Korsinsky has launched an investigation into whether previous executive statements regarding the program’s progress misled investors about the study's risks and ultimate outcome.
AstraZeneca investors are facing a potential securities investigation after the company’s stock plunged more than 8.3% on July 9, 2026. The sell-off followed the disclosure that the Phase III CARDIO-TTRansform clinical trial for the drug Wainua failed to meet its primary endpoint in treating cardiomyopathy patients.
Two turf soccer fields and a repurposed shipping container classroom opened at St. Elizabeth Parish School on July 9, marking a new chapter for an Altadena community still recovering from the devastating Eaton Fire. The facility aims to serve 1,000 local youth in its first year through sports and mentorship.
A 15.14% stock price collapse following the announcement of a $14.5 billion acquisition has triggered a formal investigation into Solstice Advanced Materials, Inc. The Pomerantz Law Firm is now probing whether the company’s leadership misled shareholders or engaged in securities fraud regarding the deal for Element Solutions.
Futu Holdings Ltd. faces a class action lawsuit following regulatory crackdowns in China that triggered significant losses for shareholders. The litigation, filed by Pomerantz LLP, centers on allegations that the online brokerage firm misled investors regarding its compliance with cross-border securities laws and the financial impact of subsequent government penalties.
Investors in GPGI, Inc. are under scrutiny as New York-based law firm Pomerantz LLP launches an investigation into potential securities fraud. The inquiry follows a sharp decline in the company’s share price earlier this year, prompting legal experts to examine whether officers misled shareholders regarding financial performance.
A 8.15% stock drop followed by a second wave of scrutiny has triggered a formal investigation into The Ensign Group. Pomerantz LLP is now examining whether the healthcare company misled shareholders regarding its business practices, specifically concerning patient care standards and Medicare billing integrity.
A 7.34% drop in Alibaba’s share price has triggered a formal investigation by Pomerantz LLP into potential securities fraud. The inquiry follows reports that the Chinese e-commerce giant allegedly used deceptive practices to bypass restrictions and gain illicit access to Anthropic’s proprietary Claude AI model.
A scathing report alleging undisclosed self-dealing by EquipmentShare founders has triggered an investigation by Pomerantz LLP into potential securities fraud. The inquiry follows a sharp 17.55% decline in the company’s stock price, which plummeted after claims surfaced regarding millions in transactions benefiting insiders.
A sharp 19.12% drop in Omeros Corporation stock has triggered a formal investigation by Pomerantz LLP. The inquiry centers on potential securities fraud following the European Medicines Agency's decision to issue a negative opinion on the company's marketing application for its lead drug candidate, narsoplimab.
When Copart CEO Jeff Liaw announced his surprise departure on June 29, 2026, the company’s share price tumbled 8.02% to close at $28.10. That sharp market reaction prompted the New York-based Pomerantz LLP to launch a formal investigation into potential securities fraud and executive misconduct at the firm.
A 23.66% drop in ON Semiconductor stock following the announcement of a $7 billion acquisition of Synaptics Incorporated has triggered a formal investigation by Pomerantz LLP. The firm is currently probing whether the deal involved securities fraud or breaches of fiduciary duty by company leadership.
Investors who purchased Black Rock Coffee Bar securities following the company's September 2025 IPO are now confronting a class action lawsuit. Pomerantz LLP has launched the litigation, targeting allegations of securities fraud and unlawful business practices that surfaced after the firm missed key financial growth benchmarks earlier this year.
A 36.4% plunge in Photronics, Inc. stock following a dismal second-quarter earnings report has triggered a class action lawsuit. Investors are now seeking lead plaintiff status by September 4, 2026, as Pomerantz LLP investigates allegations of securities fraud and misleading business practices tied to the company’s recent performance collapse.
A sharp decline in Hyliion Holdings stock has triggered a formal investigation by Pomerantz LLP into potential securities fraud. The inquiry centers on allegations that the company misled investors regarding the legitimacy of a major commercial deal, raising questions about the firm's true business substance and pipeline valuation.
A 12.38% single-day stock drop followed by a 22.51% slide has triggered an investigation into Wheels Up Experience Inc. by Pomerantz LLP. The inquiry centers on whether the private aviation company and its leadership misled investors or engaged in unlawful business practices amid deteriorating financial performance and a forced reverse stock split.
A 93.4% collapse in Megan Holdings’ share price has triggered a class action lawsuit, with investors now facing a September 8, 2026, deadline to seek appointment as lead plaintiff. The litigation centers on allegations of a coordinated social media scheme used to inflate the company’s valuation.
A 8.7% drop in Elastic N.V.’s share price has triggered a formal investigation by Pomerantz LLP. The inquiry examines whether the company or its executives committed securities fraud following the announcement of a workforce reduction and the sudden resignation of Chief Product Officer Ken Exner.
Pomerantz LLP is investigating potential securities fraud at Jefferies Financial Group following a series of disclosures linked to the bankruptcy of auto parts supplier First Brands Group. The inquiry examines whether Jefferies and its leadership misled investors regarding exposure to the distressed firm and its asset-management affiliates.
Shares of Alarum Technologies plummeted 61.85% over two trading sessions after federal authorities seized internet domains linked to the company’s NetNut subsidiary. The stock collapse followed reports that the FBI is examining whether the firm improperly utilized residential internet devices to create an unauthorized proxy network for users.
A 12.85% single-day collapse in Franklin Covey’s stock price has triggered a formal investigation by Pomerantz LLP. The inquiry examines whether the company or its leadership misled shareholders regarding financial performance and operational risks, following a disappointing third-quarter earnings report that forced a downward revision of annual revenue guidance.
Investors in Larimar Therapeutics are facing a potential class action suit as Pomerantz LLP probes the company for possible securities fraud. The investigation centers on recurring safety concerns regarding nomlabofusp, a treatment for Friedreich’s ataxia, which triggered significant stock price drops following disclosures of severe patient reactions.
Investors who purchased Black Rock Coffee Bar, Inc. securities between September 2025 and May 2026 face an August 17, 2026, deadline to seek lead plaintiff status in a pending class action lawsuit. The litigation targets alleged misrepresentations regarding the company’s expansion strategy and its impact on financial performance.
A 12% single-day stock drop on April 28, 2026, has triggered a formal investigation into Blaize Holdings, Inc. The inquiry centers on allegations that the company issued materially misleading business information, specifically concerning a $50 million deal with NeoTensr that short seller Pelican Way Research claims is fraudulent.
Investors who purchased Verra Mobility Corporation common stock between February 24 and May 26, 2026, face an August 4 deadline to apply for lead plaintiff status in a pending securities fraud class action. The lawsuit alleges the company misled shareholders regarding its critical relationship with Avis Budget Group.
A coalition of state legislators and labor supporters will gather at the MGB headquarters in Somerville this Friday, marking the third day of a week-long walkout by home care clinicians. The demonstration seeks to pressure Mass General Brigham into finalizing a first union contract that guarantees protections for regional home-based care staff.
